@article{lauretto2026,
  title={Childhood Obesity And Incretin Therapies With GLP-1 And GIP Receptor Agonists: Efficacy, Safety, And Prospects For Semaglutide And Tirzepatide In Children And Adolescents},
  author={Larissa Lauretto and Vitor Dácio Medeiros and Vitória de Almeida Rolim Rabelo and Taciane Barbosa Lopes and Joana de Alencar Benevides and Thalita Pinheiro Morel Alineri and Gabriela Coelho de Freitas Montalvão and Fernanda Maryah Leão Cunha Freitas and Melissa Farias Costa de Oliveira and Rebecca de Sousa Santana and Sumaia Andrade Taha and Camila Bassi and Tâmara Gabriela da Silva and Leticia Cantarino Corrêa and Abigail Brito Bezerra and Maiane Malaquias Martins and Geizon Lee Ed Ames Ferreira de Oliveira and Rodrigo Irente de Lima and Glaucia da Silva Siqueira and Andrya Karla Correa Presença and Délio Tiago Martins Malaquias and Regina Aparecida da Conceição Cirino and Regilane da S Batista and Filipe JL Garcia and Eliane Moreira da Silva and Lucas de Souza Vieira and Aline Cristina Couto da Silva and Liliana M. Occulate and Carlos Henrique Batista Figueiredo de Mendonça and Amanda Batista Ferreira da Silva and Mateus Soares Santos Araújo and João Marcelo Vieira Morais and Rodrigo dos Santos Oliveira Alves and Vinicius Lopes Alves and Thiago Augusto Rochetti Bezerra},
  journal={Journal of Diabetology Research},
  year={2026},
  doi={10.52338/jodr.2026.6303}
}